Officer and Director Stock Option Grant

Rita Jain, a director at Avalo Therapeutics, Inc. (AVTX), was granted 1080 stock options on June 30, 2026. The options, with an exercise price of $18.48, are for common stock and have an expiration date of June 30, 2036. These options are 100% vested as of the grant date. The transaction was reported on July 2, 2026, with Christopher Sullivan acting as attorney-in-fact for the signature.